Helen Louise Collins - Jun 21, 2022 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
Director
Signature
Teresa Bair, Attorney-in-fact for Helen Collins
Stock symbol
KURA
Transactions as of
Jun 21, 2022
Transactions value $
$0
Form type
4
Date filed
6/23/2022, 04:54 PM
Previous filing
Jul 29, 2021
Next filing
Feb 27, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KURA Option to purchase common stock Award $0 +23K $0.00 23K Jun 21, 2022 Common Stock 23K $14.84 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in full on the one year anniversary of the date of grant.